Literature DB >> 26267662

Long-term objective esthetic outcome after breast-conserving therapy.

André Hennigs1, Benjamin Hartmann, Geraldine Rauch, Michael Golatta, Patrik Tabatabai, Christoph Domschke, Sarah Schott, Florian Schütz, Christof Sohn, Joerg Heil.   

Abstract

The prediction of unfavorable long-term esthetic outcome (AO) is important for patient consultation. We aimed to analyze variables characterizing the improvement and impairment of AO over time after breast-conserving surgery. A subgroup of a prospective, monocenter cohort study was analyzed to evaluate the results of the BCCT.core software (Breast Cancer Conservative Treatment.cosmetic results) which was used to objectively assess the AO before (n = 356), shortly after (n = 294) and in median 3 years after surgery (n = 356). We analyzed potential influencing factors (such as body mass index, (y)pT-stage, weight of resected specimen, etc.) on the AO using logistic regression analyses (n = 256). Finally, we tried to characterize groups of patients with improving or impaired AO over time (n = 294). Predictors for an unfavorable AO were an axillary lymphadenectomy (OR = 4.05), a tumor in the 12 o'clock position (OR = 2.22), a tumor stage larger or equal to (y)pT2 stage (OR = 2.11), and a surgical specimen weight >75 g (OR = 2.71). Patients with lower specimen weight were more likely to improve in the long-term follow-up (p = 0.018), whereas patients with a higher (y)pT-stage tended to become impaired with time. Although overall AO decreased over time, nearly half of the patients with an unfavorable AO shortly after surgery improved in the long-term follow-up. Predictors of unfavorable AO can be used in patient consultation preoperatively to prepare them for the postsurgical period and/or to recommend surgical alternatives (e.g., more complex oncoplastic techniques). Knowledge of improvement and impairment may help patients and physicians in the postsurgical consultation setting.

Entities:  

Mesh:

Year:  2015        PMID: 26267662     DOI: 10.1007/s10549-015-3540-y

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  14 in total

1.  Correlation of Specimen/Breast Volume Ratio to Cosmetic Outcome After Breast Conserving Surgery.

Authors:  Tarek Hashem; Ahmed Morsi; Ahmed Farahat; Tarek Zaghloul; Amira Hamed
Journal:  Indian J Surg Oncol       Date:  2019-08-16

2.  Modern Breast Cancer Surgery 1st Central-Eastern European Professional Consensus Statement on Breast Cancer.

Authors:  Zoltán Mátrai; Péter Kelemen; Csaba Kósa; Róbert Maráz; Attila Paszt; Gábor Pavlovics; Ákos Sávolt; Zsolt Simonka; Dezső Tóth; Miklós Kásler; Andrey Kaprin; Petr Krivorotko; Ferenc Vicko; Piotr Pluta; Agnieszka Kolacinska-Wow; Dawid Murawa; Jerzy Jankau; Slawomir Ciesla; Daniel Dyttert; Martin Sabol; Andrii Zhygulin; Artur Avetisyan; Alexander Bessonov; György Lázár
Journal:  Pathol Oncol Res       Date:  2022-06-15       Impact factor: 2.874

3.  Patient-reported outcome measurement compared with professional judgment of cosmetic results after breast-conserving therapy.

Authors:  A T P M Brands-Appeldoorn; A J G Maaskant-Braat; W A R Zwaans; J P Dieleman; K E Schenk; C L Broekhuysen; H Weerdenburg; R Daniels; V C G Tjan-Heijnen; R M H Roumen
Journal:  Curr Oncol       Date:  2018-12-01       Impact factor: 3.677

4.  Comparison of brachytherapy and external beam radiotherapy boost in breast-conserving therapy: Patient-reported outcome measures and aesthetic outcome.

Authors:  I Kindts; A Laenen; M Christiaens; H Janssen; E Van Limbergen; C Weltens
Journal:  Strahlenther Onkol       Date:  2018-08-23       Impact factor: 3.621

Review 5.  Paradigm shift in the local treatment of breast cancer: mastectomy to breast conservation surgery.

Authors:  Kowsi Murugappan; Apoorva Saboo; Lu Kuo; Owen Ung
Journal:  Gland Surg       Date:  2018-12

6.  Oncoplastic Breast Conserving Surgery: Aesthetic Satisfaction and Oncological Outcomes.

Authors:  Sevgi Kurt Yazar; Dinçer Altınel; Merdan Serin; Şefika Aksoy; Memet Yazar
Journal:  Eur J Breast Health       Date:  2018-01-01

7.  Early health technology assessment of magnetic resonance-guided high intensity focused ultrasound ablation for the treatment of early-stage breast cancer.

Authors:  Floortje M Knuttel; Sèvrin E M Huijsse; Talitha L Feenstra; Chrit T W Moonen; Maurice A A J van den Bosch; Erik Buskens; Marcel J W Greuter; Geertruida H de Bock
Journal:  J Ther Ultrasound       Date:  2017-08-01

8.  Aesthetic result after breast-conserving therapy is associated with quality of life several years after treatment. Swedish women evaluated with BCCT.core and BREAST-Q™.

Authors:  Cecilia Dahlbäck; Jenny Heiman Ullmark; Martin Rehn; Anita Ringberg; Jonas Manjer
Journal:  Breast Cancer Res Treat       Date:  2017-05-23       Impact factor: 4.872

9.  Intraoperative ultrasound reduces the need for re-excision in breast-conserving surgery.

Authors:  Hasan Karanlik; Ilker Ozgur; Dilek Sahin; Merdan Fayda; Semen Onder; Ekrem Yavuz
Journal:  World J Surg Oncol       Date:  2015-11-24       Impact factor: 2.754

10.  Breast-conserving surgery following neoadjuvant therapy-a systematic review on surgical outcomes.

Authors:  José H Volders; Vera L Negenborn; Pauline E Spronk; Nicole M A Krekel; Linda J Schoonmade; Sybren Meijer; Isabel T Rubio; M Petrousjka van den Tol
Journal:  Breast Cancer Res Treat       Date:  2017-12-06       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.